TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/13/2026
Back to search
Official data from USPTO
MAYO CLINIC PHARMACY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MAYO CLINIC PHARMACY
ST13
US500000076442208Class
35
Filing
76442208
Registration
2719318
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
01/15/2026
Trademark type
Word
Nice classes
35
Filing date
08/21/2002
Registration date
05/27/2003
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/16/2023
Last transaction
01/15/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
2001-10-00
First use in commerce
2001-10-00
Drawing code
1
Owner type
99
Owner location
Rochester, MN, US
Examiner
MCMORROW, RONALD G
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Mayo Foundation for Medical Education and Research
Representatives
Timothy M. Kenny Norton Rose Fulbright US LLP
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Pharmacy Services
Publications
History of USPTO decisions and trademark events.
26 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/13/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/13/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/13/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/13/2026
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/16/2023
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
10/16/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/16/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/16/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
04/14/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/27/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/03/2012
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/03/2012
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/03/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/03/2012
E89R
TEAS SECTION 8 & 9 RECEIVED
10/10/2012
CFIT
CASE FILE IN TICRS
03/03/2009
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/13/2009
PLGL
ASSIGNED TO PARALEGAL
02/11/2009
E815
TEAS SECTION 8 & 15 RECEIVED
02/09/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
05/27/2003
PUBO
PUBLISHED FOR OPPOSITION
03/04/2003
NPUB
NOTICE OF PUBLICATION
02/12/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/31/2002
CNEA
EXAMINER'S AMENDMENT MAILED
12/30/2002
DOCK
ASSIGNED TO EXAMINER
12/24/2002
Continuous trademark protection
Get notified about every new filing that threatens MAYO CLINIC PHARMACY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.